PPR indicates prednisone poor response; MRD, minimal residual disease; Protocol IB, cyclophosphamide, cytarabine, 6-mercaptopurine consolidation; ADE/MAE, cytarabine, daunorubicin, etoposide/mitoxantrone, cytarabine, etoposide consolidation; and TKI, tyrosine kinase inhibitor.